‘Remdesivir Papers’ Allege Controversial Drug Used to Treat Service Members Led to 601 Deaths, by Michael Nevradakis

Kamala Harris Claims To ‘Love America,’ But Her Record Shows She Hates It, by John Daniel Davidson

October 8, 2024

Supreme Court Allows Texas Abortion Ban to Stay in Place Protecting Babies, by Steven Ertelt

October 8, 2024

Remdesivir-papers-ignored-trials-feature. Source: Children's Health Defense

By Michael Nevradakis, Ph.D., Children’s Health Defense, October 7, 2024

Michael Nevradakis, Ph.D., based in Athens, Greece, is a senior reporter for The Defender and part of the rotation of hosts for CHD.TV’s “Good Morning CHD.”

Updated: This article was updated to correct the number of deaths linked to remdesivir.

A military whistleblower released a series of documents revealing that the military began “liberally” administering remdesivir to service members who were suspected of having COVID-19 — months before the FDA approved the drug.

A military whistleblower released a series of documents revealing 601 deaths of military service members and a high rate of serious adverse events in clinical trials involving remdesivir, an antiviral commonly administered to COVID-19 patients during the pandemic.

According to “The Remdesivir Papers,” some clinical trials were improperly run. In the case of at least one study, results were never made public. The whistleblower also alleged a widespread lack of informed consent for trial participants.

“Data derived from the Department of Defense [DOD] Joint Trauma System … by a military whistleblower offers a stark contrast to results of multiple clinical trials involving the liberal usage of remdesivir in military treatment facilities and other civilian facilities, as well as its potential contribution to, at minimum, hundreds of untimely deaths,” the documents state. …

‘Remdesivir Papers’ Allege Controversial Drug Used to Treat Service Members Led to 601 Deaths, by Michael Nevradakis

Kamala Harris Claims To ‘Love America,’ But Her Record Shows She Hates It, by John Daniel Davidson

Supreme Court Allows Texas Abortion Ban to Stay in Place Protecting Babies, by Steven Ertelt

By Michael Nevradakis, Ph.D., Children’s Health Defense, October 7, 2024

A military whistleblower released a series of documents revealing that the military began “liberally” administering remdesivir to service members who were suspected of having COVID-19 — months before the FDA approved the drug.

A military whistleblower released a series of documents revealing 601 deaths of military service members and a high rate of serious adverse events in clinical trials involving remdesivir, an antiviral commonly administered to COVID-19 patients during the pandemic.

According to “The Remdesivir Papers,” some clinical trials were improperly run. In the case of at least one study, results were never made public. The whistleblower also alleged a widespread lack of informed consent for trial participants.

Continue reading >>>>>>>>>>>>>>

Related posts

CatholicVote: Archbishop Of New Orleans Releases Statement After Terror Attack at New Year’s Eve Gathering

Daily Scripture Readings and Meditations: Christ Stands Among You

Archbishop Fulton Sheen’s Powerful Words to President Jimmy Carter, by Joseph Pronechen